Esketamine Hcl
Brand name: Spravato
Rank #345 of 500 drugs by total cost
$29.0M
Total Cost
20,816
Total Claims
$29.0M
Total Cost
393
Prescribers
$1,393
Cost per Claim
353
Beneficiaries
20,822
30-Day Fills
$74K
Avg Cost/Provider
53
Avg Claims/Provider
About Esketamine Hcl
Esketamine Hcl (sold as Spravato) was prescribed 20,816 times by 393 Medicare Part D providers in 2023, costing the program $29.0M. At $1,393 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 342 | Hydroxyzine Hcl (Hydroxyzine Hcl) | $30.2M | 1,474,936 |
| 343 | Irbesartan (Irbesartan) | $30.1M | 869,928 |
| 344 | Amiodarone Hcl (Amiodarone Hcl) | $29.9M | 1,007,679 |
| 345 | Esketamine Hcl (Spravato) | $29.0M | 20,816 |
| 346 | Warfarin Sodium (Warfarin Sodium) | $28.9M | 2,126,832 |
| 347 | Ivosidenib (Tibsovo) | $28.9M | 931 |
| 348 | Cyclobenzaprine Hcl (Cyclobenzaprine Hcl) | $28.7M | 2,582,519 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology